Table 1.
Participant Class | Sample Size | Median Age (Range) | |
---|---|---|---|
Pancreatic Adenocarcinoma | |||
Total | 75 | 69 (48-92) | |
Female | 29 | 76 (52-94) | |
Male | 46 | 65 (48-92) | |
Stage IA | 1 | ||
Stage IB | 3 | ||
Stage IIA | 7 | ||
Stage IIB | 24 | ||
Stage III | 17 | ||
Stage IV | 23 | ||
Healthy Control | |||
Total | 150 | 66 (30-94) | |
Female | 58 | 65.5 (52-94) | |
Male | 92 | 66.5 (30-91) | |
Chronic Pancreatitis | |||
Total | 32 | 50 (32-77) | |
Female | 15 | 50 (34-63) | |
Male | 17 | 47 (32-77) | |
Benign Neoplasm and Periampullary Lesions |
|||
Total | 42 | 70.5 (41-91) | |
Female | 22 | 70 (41-84) | |
Male | 20 | 71.5 (49-91) | |
intraductal papillary mucinous tumor | 13 | ||
mucinous cystic neoplasm | 12 | ||
neuroendocrine tumor | 5 | ||
serous cystadenoma | 4 | ||
cystic neuroendocrine neoplasm | 3 | ||
bile duct stricture | 3 | ||
solid-cystic papillary neoplasm | 2 |